Lilly Cialis Head-To-Head Viagra Studies Are Not Enough To Compare – EMEA
Executive Summary
Comparative studies submitted in Lilly/Icos' Cialis EU application do not support conclusions about comparative efficacy or safety of the erectile dysfunction therapy versus Pfizer's Viagra, European approval documents maintain